Document is current

Any future updates will be listed below

Cadonilimab is effective and safe in recurrent cervical cancer

Crossref DOI link: https://doi.org/10.1038/s41571-024-00962-3

Published Online: 2024-10-25

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark